DRIEHAUS CAPITAL MANAGEMENT LLC – Apellis Pharmaceuticals, Inc. Transaction History
DRIEHAUS CAPITAL MANAGEMENT LLC portfolio value:
$58.61M
portfolio value
DRIEHAUS CAPITAL MANAGEMENT LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +12.89% | 97.98K shares | 24.23M | $68.3 | 858.13K |
| Q2 2022 | share | Increase | +20.92% | 131.50K shares | 2.43M | $45.22 | 760.14K |
| Q1 2022 | share | Increase | +139.12% | 365.74K shares | 19.51M | $50.81 | 628.64K |
| Q4 2021 | share | Decrease | -4.59% | -12.65K shares | 3.34M | $47.95 | 262.89K |
| Q3 2021 | share | Increase | +6.23% | 16.15K shares | -7.31M | $32.96 | 275.55K |
| Q2 2021 | share | Decrease | -1.61% | -4.24K shares | 5.08M | $63.2 | 259.39K |
| Q1 2021 | share | Decrease | -32.39% | -126.31K shares | -10.99M | $42.91 | 263.64K |
| Q4 2020 | share | Increase | +0.49% | 1.91K shares | 10.59M | $57.2 | 389.95K |
| Q3 2020 | share | Decrease | -8.87% | -37.75K shares | -2.19M | $30.17 | 388.03K |
| Q2 2020 | share | Decrease | -16.91% | -86.67K shares | 177K | $32.66 | 425.79K |
| Q1 2020 | call | Decrease | -100.00% | -75K shares | -372K | $26.79 | 0 |
| Q1 2020 | share | Increase | +12.22% | 55.80K shares | -254K | $26.79 | 512.47K |
| Q4 2019 | share | Increase | +225.39% | 316.32K shares | 10.60M | $30.62 | 456.66K |
| Q4 2019 | call | Increase | 0.00% | 75K shares | 372K | $30.62 | 75K |
| Q3 2019 | share | Increase | 0.00% | 140.34K shares | 3.38M | $24.09 | 140.34K |